NCT07031570View on ClinicalTrials.gov

Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Colorectal Cancer Metastatic
All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER